Drug Type Monoclonal antibody |
Synonyms Anti-KL49 Capsular Polysaccharide Antibody (Kymab) |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acinetobacter Baumannii Infection | Preclinical | GB | 12 Sep 2024 |